Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic

Timothy A. Chan(Memorial Sloan Kettering Cancer Center), Mark Yarchoan(Sidney Kimmel Comprehensive Cancer Center), Elizabeth M. Jaffee(Sidney Kimmel Comprehensive Cancer Center), Charles Swanton(The Francis Crick Institute), Sergio A. Quezada(London Cancer), Albrecht Stenzinger(German Cancer Research Center), Solange Peters(University Hospital of Lausanne)
Annals of Oncology
November 1, 2018
Cited by 2,870Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis